Evaluation of prothrombin complex concentrate, recombinant activated factor VII and fibrinogen concentrate to reverse apixaban in a rabbit model

被引：0
|
作者：
Martin, A-C. [1 ]
Le Bonniec, B. [2 ]
Lecompte, T. [3 ]
Dizier, B. [2 ]
Emmerich, J. [2 ]
Fischer, A-M. [4 ]
Samama, C-M. [5 ]
Godier, A. [5 ]
机构：
[1] Mil Hosp HIA Val de Grace, Paris, France
[2] Paris Descartes Univ, Inserm U765, Paris, France
[3] Univ Hosp Nancy, Nancy, France
[4] Hop Europeen Georges Pompidou, AP HP, Paris, France
[5] Hosp Hotel Dieu, AP HP, Paris, France
来源：
CARDIOVASCULAR RESEARCH | 2012年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [31] Retrospective Comparison of Recombinant Activated Factor VII Versus 4-Factor Prothrombin Complex Concentrate in Cardiac Surgical Patients
    Faraoni, David
    Guindi, Anna
    Ankola, Ashish A.
    Resheidat, Ashraf
    Binsalamah, Ziyad
    Teruya, Jun
    Savorgnan, Fabio
    Vener, David F.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2024, 38 (02) : 388 - 393
  • [32] More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate
    Lindahl, Tomas L.
    Wallstedt, Maria
    Gustafsson, Kerstin M.
    Persson, Egon
    Hillarp, Andreas
    THROMBOSIS RESEARCH, 2015, 135 (03) : 544 - 547
  • [33] Rapid Warfarin Reversal in the Setting of Intracranial Hemorrhage: A Comparison of Plasma, Recombinant Activated Factor VII, and Prothrombin Complex Concentrate
    Woo, Carolyn H.
    Patel, Nihar
    Conell, Carol
    Rao, Vivek A.
    Faigeles, Bonnie S.
    Patel, Minal C.
    Pombra, Jasmeen
    Akins, Paul T.
    Axelrod, Yekaterina K.
    Ge, Ivy Y.
    Sheridan, William F.
    Flint, Alexander C.
    WORLD NEUROSURGERY, 2014, 81 (01) : 110 - 115
  • [34] Four-factor prothrombin complex concentrate reverses apixaban-associated bleeding in a rabbit model of acute hemorrhage
    Herzog, E.
    Kaspereit, F.
    Krege, W.
    Mueller-Cohrs, J.
    Doerr, B.
    Niebl, P.
    Dickneite, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (12) : 2220 - 2226
  • [35] Activated prothrombin complex concentrate for acquired haemophilia when recombinant factor VIIa fails
    Hussein, Z.
    Kudva, G. C.
    Reimers, H. J.
    HAEMOPHILIA, 2009, 15 (03) : 831 - 832
  • [36] EFFECT OF TREATMENT WITH ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (FEIBA) ON FACTOR-VII-ANTIBODY LEVEL
    LECHNER, K
    NOWOTNY, C
    KRINNINGER, B
    ZEGNER, M
    DEUTSCH, E
    THROMBOSIS AND HAEMOSTASIS, 1979, 40 (03) : 478 - 485
  • [37] Efficacy of prothrombin complex concentrate to reverse the anticoagulant effect of the pentasaccharide fondaparinux in a rabbit model
    Godier, Anne
    Durand, Marion
    Emmerich, Joseph
    Dizier, Blandine
    Lecompte, Thomas
    Samama, Charles-Marc
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (01) : 161 - 168
  • [38] Fibrinogen and prothrombin complex concentrate in trauma coagulopathy
    Hannon, Matthew
    Quail, Jacob
    Johnson, Matthew
    Pugliese, Cara
    Chen, Kejian
    Shorter, Heidi
    Riffenburgh, Robert
    Jackson, Ronald
    JOURNAL OF SURGICAL RESEARCH, 2015, 196 (02) : 368 - 372
  • [39] COST MINIMIZATION OF USING ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE VERSUS RECOMBINANT ACTIVATED FACTOR VII IN PATIENTS WITH A ND B HEMOPHILIA IN PRESENCE OF INHIBITORS
    Romero Prada, M. E.
    Gomez de la Rosa, F.
    Alvis-Zakzuk, N. J.
    Carrasquilla-Sotomayor, M.
    Alvis-Zakzuk, J. S.
    Zakzuk-Sierra, J.
    VALUE IN HEALTH, 2016, 19 (07) : A433 - A433
  • [40] Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa
    Barton, Cassie A.
    Hom, Marissa
    Johnson, Nathan B.
    Case, Jon
    Ran, Ran
    Schreiber, Martin
    AMERICAN JOURNAL OF SURGERY, 2018, 215 (05): : 775 - 779
12345